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Active Ocular Toxoplasmosis in Patients Diagnosed and 
Treated at General Hospital Zadar
Aktivna okularna toksoplazmoza pacijenata dijagnosticiranih i 
liječenih u Općoj bolnici Zadar
Abstract
Toxoplasma gondii is responsible for the 20-60% of all the cases of chorioretinitis. 
Causes of permanently reduced vision (found in about 25% of the patients) include 
macular active lesions and macular oedema, optic nerve involvement, vascular 
occlusion, retinal detachment, and late secondary choroidal neovascularization. 
A retrospective, non-consecutive chart review was performed on 11 patients 
with active ocular toxoplasmosis. At examination, all patients had central ac-
tive lesions on retina. Preexisting chorioretinal scars were found in seven pa-
tients (63.6%). Eight patients (72.7%) had vitritis, while three patients (27,3%) 
had iridocyclitis. Six patients (54.6%) had macular inflammatory lesions, four 
(36,37%) of them had active lesions out of vascular arcades, and one (9.1%) 
had active lesions inside vascular arcades, while macula was not affected. The 
mean value of visual acuity at first visit of the patients was 0,5. The mean value 
of visual acuity was 0.9 after the healing process. All the patients were treat-
ed with oral antibiotics. Seven patients also received oral corticosteriods, and 
seven of them were also treated with pyrimethamine. All patients with signs of 
iridocyclitis were also treated with topical corticosteroids. Although toxoplas-
mosis chorioretinitis is usually a self-limited infection and generally resolves 
spontaneously, unrecognised cases can result in severe visual impairments.
Sažetak
Toxoplasma gondii je uzročnik 20-60 % svih slučajeva korioretinitisa. Uzroci 
trajno smanjenog vida (slučaj kod otprilike 25% pacijenata) uključuju aktivne 
lezije u makuli, makularni edem, lezije optičkog živca, vaskularne okluzije, 
ablacije mrežnice i kasne  koroidalne neovaskularizacije. Prilikom pregleda, 
svi su pacijenti imali aktivne lezije na mrežnici. Raniji korioretinalni ožiljci 
pronađeni su u sedam pacijenata (63,6%). Osam pacijenata je imalo vitritis 
(72,7%), dok su tri pacijenta imala iridociklitis (27,3%). Šest pacijenata (54,6 
%) imalo je upalne lezije u makuli, četvero (36,37%) je imalo aktivne lezije 
izvan krvožilnih arkada, a jedan (9,1%) je imao aktivne lezije unutar krvožil-
nih arkada, dok makula nije bila zahvaćena. Srednja vrijednost vidne oštrine 
prilikom prvog pregleda bila je 0,5. Poslije izlječenja srednja vrijednost vidne 
oštrine bila je 0,9. Svi pacijenti liječeni  su peroralnim antibioticima. Sedam 
pacijenata je, također, primilo peroralne kortikosteroide, a sedam pirimetamin. 
Svi pacijenti s iridociklitisom su, također, primili topičke kortikosteroide. Iako 
je korioretinitis uzrokovan toksoplazmozom uobičajeno samolimitirajuća bo-
lest koja se može spontano izliječiti, nedijagnosticirani slučajevi mogu rezulti-
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Introduction
 Ocular toxoplasmosis is caused by the protozoan 
parasite Toxoplasma gondii and it infects humans and 
warm-blooded animals. Toxoplasmosis prevalence varies 
worldwide which depends on climate, eating habits and 
hygiene, but the incidence is higher in tropical areas and 
decreases with increasing latitude [1-5].
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 We performed serologic tests, including serum IgG 
and IgM antibodies against Toxoplasma gondii using en-
zyme-linked immunosorbent assay-ELISA.
 All patients underwent ophtalmological examination, 
including best-corrected Snellen visual acuity, slit-lamp 
examination, Goldmann tonometry and indirect ophthal-
moscopy.
 The presence of anterior chamber and vitreous inflam-
mation was studied according to the SUN Working Group 
Grading system for anterior chamber cells and vitreous 
haze.
 Demographic information, clinical features, systemic or 
topical treatments and treatment outcomes were recorded.
 After obtaining necessary data, statistical analysis was 
conducted. SPSS for WINDOWS (version 13.0 SPSS Inc. 
Chicago, Illinos, USA) and Microsoft Excell (version of 
Office 2007, Microsoft Corporation, Redmont, WA, USA) 
were used. Nominal variables are represented as absolute 
(number) and relative (percentage) frequency.
Results
 This retrospective chart review included 11 patients 
diagnosed with active ocular toxoplasmosis (Figure 1). 
The demographic and general characteristics of the partici-
pants in the study are summarized in the Table 1.
 It is responsible for the 20-60% of all the cases of 
chorioretinitis. This disease has predilection spot for the 
posterior pole. The infection is usually unilateral and the 
lesions can be isolated, multiple or satellite to a pigmented 
retinal scar. The infection begins in the superficial layers 
of retina and then affects the retinal pigment epithelium 
and choroid. Characteristic of retinitis is focal necrotiz-
ing retinitis resulting in atrophic scars. Retinitis can be 
accompanied with choroiditis, vasculitis, haemorrhage, 
vitritis and anterior uveitis [6].
 The complications can be vision-threatening such as 
choroidal neovascularisation, glaucoma, optic nerve atro-
phy, rhegmatogenous and exudative retinal detachment, 
retinal vessel occlusion, epiretinal membrane formation 
and cataract. Rhegmatogenous retinal detachments, for 
example, have been related to the severity of inflamma-
tion [7].  Prolonged infections, intense inflammation, and 
complications can occasionally result with phthisis or 
enucleation[8-9].  It is progressive and reccurent disease 
and patients have to be monitored after the healing process 
to avoid late complications.
 Ocular toxoplasmosis can be a consequence of con-
genital or acquired infection. For a long time, ocular tox-
oplasmosis was considered to be a result of recurrence of 
the congenital infection[10].  However, recent research-
es support the theory that acquired infections might be a 
more important cause of ocular diseases than congenital 
ones [11-13]. The age of first onset of ocular symptoms 
is one of the clinical characteristics that is expected to be 
helpful in making a distinction between prenatal and post-
natal Toxoplasma gondii infection. A study from French 
authors showed that ocular lesions in congenitally infect-
ed children occur mainly before the age of 5 years and 
almost always before the age of 10 years [14].
 The aim of this study is to report clinical features of 
patients who were diagnosed, treated and had control 
check ups at least 6 months after an episode of active ocu-
lar toxmoplasmosis at General Hospital Zadar.
Methods
 The retrospective analysis (retrospective chart review) 
of medical records of patients diagnosed with active oc-
ular toxoplasmosis at the Department of Opthalmology 
of the General Hospital Zadar was conducted. All partici-
pants were diagnosed with ocular toxoplasmosis and treat-
ed in the period between January 2010 and January 2018.
 The inclusion criteria were proven diagnosis of ocu-
lar toxoplasmosis and a minimum six months follow-up. 
The patients with acquired immunodeficiency syndrome 
(AIDS) were excluded.
 The diagnosis was based on the presence of active 
creamy-white focal necrotizing retinitis, with or without 
preexisting chorioretinal scars. The diagnosis was sup-
ported by serologic tests.
Figure 1. Fundus of a Patient with Ocular Toxoplasmosis at the 
Initial Examination
Slika 1. Fotografija fundusa bolesnika s očnom toksoplazmozom 
pri prvom pregledu
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active protein, liver and kidney functions tests were within 
normal range in all patients.
 All patients had unilateral involvements.
 The patients had no extraocular involvements.
 Recurrent ocular toxoplasmosis is defined as an active 
focal retinal lesion in the presence of old chorioretinals 
scar. The preexisting chorioretinal scars were found in 
seven patients which means that the recurrence was present 
in 63.6% of patients. In seven patients, this was the first 
diagnosed episode of ocular toxoplasmosis. Four patients 
had previous episodes of toxoplasmosis chorioretinitis. 
One patient had two previous episodes, two of them had 
three and one of them had four previous episodes. Since 
four patients had previous episodes of toxoplasmosis cho-
rioretinitis, three of them had previous subclinical episode.
 All patients were treated with oral antibiotics, azithro-
mycin (250 mg per day) or  sulfamethoxazole/trimethop-
rim (800/160 mg twice daily). 
 Seven patients were treated with oral corticosteriods 
prednisolone (0.5 mg – 1 mg/kg/day depending on the se-
verity of the inflammation).
 Seven patients were treated with pyrimethamine 200 
mg orally, once on the first day, followed by 50 mg orally 
 All of them were diagnosed, treated and had control 
check ups at least 6 months after an episode of chorioreti-
nitis at General Hospital Zadar.
 Eight patients were female, and three patients were 
male.
 The age range of patients was 15 to 65 years and the 
mean age of the patients was 42.73.
 The mean value of visual acuity at first patients’ visit 
was 0,5 with the range from 0.05 to 1. After the healing 
process, the mean value of visual acuity was equal or bet-
ter in all patients. The mean value of visual acuity after the 
healing process was 0.9 with the range from 0.33 to 1.
 At examination, all patients had active lesions on 
retina. The preexisting chorioretinal scars were found in 
seven patients (63.64%). Eight patients (72.73%) had vi-
tritis, while three patients (27.27%) had iridocyclitis. Six 
patients (54.55%) had macular inflammatory lesions, four 
(36.37%) of them had active lesions out of vascular ar-
cades, and one (9.09%) was diagnosed with active lesions 
inside vascular arcades, while macula was not affected.
 All the patients had positive serum anti-toxoplasma 
IgG antibodies, but negative IgM antibodies. Complete 
blood cell counts and erythrocyte sedimentation rate, c-re-
Table 1. Clinical Features of Patients with Active Ocular Toxoplasmosis
Tablica 1. Kliničke karakteristike bolesnika s aktivnom očnom toksoplazmozom
Case 














1 32 Female Active chorioretinitis, vitritis, chorioretinal scars 1 1 yes 3 yes yes yes
2 61 Female Active chorioretinitis, vitritis, iridocyclitis 0,25 0,75 no 0 yes yes yes
3 49 Female Active chorioretinitis, irido-cyclitis 1 1 no 0 yes no yes
4 27 Female Active chorioretinitis, vitritis, chorioretinal scars 1 1 no 0 yes no yes
5 52 Female Active chorioretinitis, vitritis 0,5 1 no 0 yes yes yes
6 47 Male Active chorioretinitis, vitritis, chorioretinal scars 0,75 1 yes 4 no yes yes
7 61 Female Active chorioretinitis, chori-oretinal scars 0,75 0,75 no 0 no no yes
8 15 Female Active chorioretinitis, vitritis, iridocyclitis 0,01 1 no 0 yes yes yes
9 65 Male Active chorioretinitis, chori-oretinal scars 0,33 0,33 no 0 no yes yes
10 45 Female Active chorioretinitis, vitritis, chorioretinal scars 0,5 1 yes 3 no yes yes
11 16 Male Active chorioretinitis, vitritis, chorioretinal scars 0,05 1 yes 2 yes no yes
1No - number, 2VA – visual acuity, 3Th – therapy
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genotypes [19].  It is believed that, except the parasite, a 
host also contributes to the development of this disease. 
The studies on the impact of host genes on infections are 
extremely important. Recent studies provide us the infor-
mation on the contribution of the host’s genetic factors on 
the development of this disease [20-22].
 We did not notice any complications after the healing 
process, which may be due to antimicrobial drug therapy in 
all patients and timely treatment, especially in immediate 
complications.  As far as the Korean study is concerned, 
34.8% of the patients had complications after acute ocu-
lar toxoplasmosis. 26.1% of patients from this study did 
not receive any anti-Toxoplasma treatment [23]. Although 
toxoplasmosis causes 20 to 60% of all the cases of chori-
onetinitis, the effectiveness of treatment remains contro-
versial. There is still no consensus regarding the choice of 
antiparasitic agents for treatment regimens. Furthermore, 
due to potential toxicity, the question is whether to treat 
all the patients, especially those who are immune-compe-
tent. Stanford et al. indicate the lack of evidence for the 
efficacy of treatment for acute toxoplasmic chorioretini-
tis [24]. They identified only three randomized controlled 
clinical trials, which were described as ‘methodologically 
poor,’ and none of which reported permanent visual out-
come. Guaraldo et al. describe the side effects associated 
with the classic treatment of ocular toxoplasmosis. Out 
of 147 patients studied, 85% of them developed one or 
more side effects [25].  However, despite the unanswered 
questions, the survey among physicians showed that most 
ophthalmologists treat immune-competent patients with 
active chororietinitis while selecting a treatment depends 
on a clinical picture [26].  We treated all the patients with 
diagnosed active ocular toxoplasmosis and we had no 
therapeutic side effects. Due to the good outcome of the 
disease, unrecorded complications of the disease, as well 
as the side effects of the medications, we believe that the 
treatment is necessary. It should be adapted to a patient 
and depends on the severity of a clinical picture.
Conclusions
 Although ocular toxoplasmosis is a self-limited dis-
ease, sometimes it can go unnoticed, especially if it does 
not reduce visual acuity, and in many cases it affects mac-
ula and seriously impairs visual acuity. Patients should 
have effective treatment and be monitored in order to 
avoid complications.
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per day and then for a period of 4 weeks. The treatment 
was combined with sulfadiazine. Sulfadiazine was admin-
istered at a dosage level of 2 g orally as a loading dose, 
followed by 1 g orally every 6 hours. 
 All patients with signs of iridocyclitis were also pre-
scribed topical corticosteroids.
 None of the patients had any side effects of the drugs.
Discussion
 Although toxoplasmosis is not newly discovered dis-
ease, there are still many issues related to it. There are 
many doubts on the factors influencing the epidemiology 
and pathophysiology of this disease that can even lead to 
blindness . We are only at the beginning of understanding 
the biology of this parasite and its mechanisms of inva-
sion, virulence and interaction with the host’s immune re-
sponse.
 Mean patients’ age in our research was higher than 
in other similar researches [7, 15, 16]. The understand-
ing of relationship between ocular toxoplasmosis and 
patient age is incomplete. The phenomena of age differ-
ence could be attributed to differences in lifestyle, such as 
eating habits and hygiene, but also to small sample size. 
The localization of active chorioretinitis in our patients 
was less frequent in the macula than in other studies. In 
our study, the macula was affected in approximately half 
of the patients, unlike in Japanese research in which the 
macula was affected in 74% of patients. Along with the 
application of an adeaquate treatment, this is a possible 
reason for good visual acuity after healing process in our 
patients [13]. In Turkish patients, preexisting chorioreti-
nal scars were found in 83% of patients, while in Kore-
an patients scars were found in 10% of patients, and in 
our and most other studies the incidence was somewhere 
beetwen. The reasons for the differences in severity of dis-
ease, recurrence and predilection spots for active lesions, 
could also be, besides different habits of population and 
different climate type, genotypic differences of infecting 
parasite. It is  known that there are three main clonal lin-
eages of Toxoplasma gondii named type I, II and III and 
they vary in their virulence [17]. Except these genotypes, 
other „atypical“ genotypes were found worldwide. A high 
occurrence of ocular toxoplasmosis in Brasil is attribut-
ed to the higher prevalence of nonarchetypal Toxoplasma 
gondii strains [18].  Keats Shwab et al. suggest that the 
expansion of farming in the past 11,000 years established 
the domestic cat/mouse transmission cycle for Toxoplas-
ma gondii, which has played a significant role in the selec-
tion of certain linages of Toxoplasma gondii. According to 
them, the domestic transmission cycle may have favoured 
the development of clonal populations dominated by gen-
otypes that are less virulent. In contrast, within natural 
environments, such as the tropical Amazon rainforest, the 
sylvatic cycle seems to favour development of a diverse 
population supporting highly virulent Toxoplasma gondii 
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